Personalizedx

This is an ongoing assignment that’s close to our hearts. The CAP Foundation, an affiliate of the College of American Pathologists, since 1963 has gra PersonalizeDx is a leading lab offering early detection of genomic changes using Fluorescence in situ Hybridization (FISH) technology. Test results may inform cancer diagnosis, quantify disease aggressiveness, and distinguish which patients are likely to be responsive to specific therapies. Abbott Molecular sought a progressive lab re-brand with PersonalizeDx, and Media Directions Creative Group met the challenge, focusing its marketing strategy on differentiated medicine targeted to each patient's unique needs. MDCG had marketed PersonalizeDx's predecessor, Cynogen, and was tapped by Abbott Molecular again to take PersonalizeDx forward. MDCG developed an icon system that signifies the different types of cancer diagnostics through color, as well as the logo, website, trade show booth, and trade advertising.  https://www.personalizedx.com/